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Alternative splicing contributes to both gene regulation and protein diversity. To discover broad relationships between
regulation of alternative splicing and sequence conservation, we applied a systems approach, using oligonucleotide
microarrays designed to capture splicing information across the mouse genome. In a set of 22 adult tissues, we observe
differential expression of RNA containing at least two alternative splice junctions for about 40% of the 6,216
alternative events we could detect. Statistical comparisons identify 171 cassette exons whose inclusion or skipping is
different in brain relative to other tissues and another 28 exons whose splicing is different in muscle. A subset of these
exons is associated with unusual blocks of intron sequence whose conservation in vertebrates rivals that of protein-
coding exons. By focusing on sets of exons with similar regulatory patterns, we have identified new sequence motifs
implicated in brain and muscle splicing regulation. Of note is a motif that is strikingly similar to the branchpoint
consensus but is located downstream of the 59 splice site of exons included in muscle. Analysis of three paralogous
membrane-associated guanylate kinase genes reveals that each contains a paralogous tissue-regulated exon with a
similar tissue inclusion pattern. While the intron sequences flanking these exons remain highly conserved among
mammalian orthologs, the paralogous flanking intron sequences have diverged considerably, suggesting unusually
complex evolution of the regulation of alternative splicing in multigene families.
Citation: Sugnet CW, Srinivasan K, Clark TA, O’Brien G, Cline MS, et al. (2006) Unusual intron conservation near tissue-regulated exons found by splicing microarrays. PLoS
Comput Biol 2(1): e4.
Introduction
Splicing is an essential process that constructs protein
coding messenger RNA (mRNA) sequences using tiny seg-
ments of information buried in the much larger primary
transcripts of the eukaryotic gene. Regulated alternative
splicing can create different protein coding sequences under
different biological circumstances, allowing the production
of functionally related but distinct proteins (for review, see
[1]). In addition, alternative splicing can mediate the
repression of gene expression by stimulating the formation
of transcripts subject to nonsense-mediated decay [2–5].
Splicing patterns seem distinct in the vertebrate nervous
system compared to other tissues [6,7], and it is tempting to
hypothesize that neural alternative splicing contributed to
the rapid evolution of the vertebrate brain without large
increases in gene number [8].
Biochemical analysis of alternative splicing has shown that
numerous RNA binding proteins inﬂuence the use of speciﬁc
splice sites to stimulate splicing events that lead to particular
mRNA isoforms [1,9]. These RNA binding proteins may
activate or repress the use of splice sites by binding to nearby
sequences in the exon (exonic splicing enhancers [ESEs] or
exonic splicing silencers [ESSs]) or in the intron (intronic
splicing enhancers [ISEs] or intronic splicing silencers [ISSs]
[1,9]). In many cases, multiple RNA binding proteins combine
to create repressing and activating inﬂuences that produce
patterns of splicing control [6,9]. Some proteins, such as SR
proteins and the CELF proteins, have mostly activating roles,
whereas others, such as hnRNP A1, PTB, and nPTB, have
mostly repressing roles. Certain proteins can either activate
or repress splicing in different contexts, depending on the
position of their binding sites or the expression of other RNA
binding proteins [10,11].
A complete catalog of the RNA sequences corresponding to
the enhancers and silencers bound by splicing regulatory
proteins would greatly aid the understanding of splicing
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splicing regulators whose corresponding RNA binding motifs
have been identiﬁed (for review, see [12]), whereas there may
be many splicing regulators among the hundreds of RNA
binding proteins encoded by the mouse genome. In addition,
several related but distinct genes produce proteins that bind
the same or overlapping sets of sequences; for example, Fox-1
and RBM9 each bind UGCAUG [13,14], and the branchpoint
binding protein SF1 and the protein quaking (QK) each bind
UACUAAC-like motifs [15–17]. Adding to this complexity is
the tendency for the mRNAs of RNA binding proteins to be
alternatively spliced, leading to multiple RNA binding protein
isoforms with potentially different functions (e.g., [14,18–20]).
Currently, the methods available for expanding the list of
known regulators and their target sequences are limited, and
the development of this catalog is in the early stage [12].
Much of the available genomic information on alternative
splicing is derived by the alignment of large numbers of
expressed sequence tags (ESTs) and messenger RNAs (high-
quality cDNA sequences) to genome sequences (for many
genomes, see [21]). The analysis of exons that appear to be
constitutive (i.e., present in every example of a transcript
from a given locus) or alternative (exons or parts of exons
that are sometimes skipped) has led to the successful
identiﬁcation of many distinguishing features of alternatively
spliced regions [22–28], even allowing their accurate pre-
diction without cDNA evidence [26,29,30]. Although cDNA
libraries have been invaluable for discovering general
features of alternatively spliced exons, it is difﬁcult to
connect speciﬁc regulatory sequences to speciﬁc biological
conditions with conﬁdence due to variable and sometimes
missing information about the source materials and methods
of cDNA library construction. The relatively low number of
transcripts present from any one gene also makes it difﬁcult
to estimate differences in expression levels using library
representation as a measure. Thus, more direct methods are
needed to associate alternative splicing events with under-
lying biological conditions.
The recent application of microarray technology to
questions of splicing and splicing regulation promises to
reveal parallel connections between many splicing events and
speciﬁc biological or experimental conditions [31–41]. Anal-
ysis of experimental changes in splicing for many genes
simultaneously should reveal biological conditions necessary
for proper splicing regulation in a way that analysis of cDNA
libraries cannot, and with breadth that cannot be achieved by
analysis of a reporter construct or a few endogenous target
genes. To demonstrate this, we constructed a DNA micro-
array designed to capture splicing information for about
6,200 alternative events in the mouse transcriptome, using a
combination of splice junction and exon probes, and have
hybridized RNA from 22 adult mouse tissues. We examine
splicing in these tissues by asking three questions.
First we ask, Which RNA isoforms are present in a
particular tissue sample? To answer this simple question, we
used a new method based on comparing the intensity of the
probes in a probe set to the distribution of intensities from
all probes with similar G þ C level. This is similar in spirit
although different in approach to the present-absent calls
from Affymetrix MAS 5.0 algorithms [42], as this microarray
did not contain mismatch probes. Using RT-PCR, we show
that this method has a true-positive rate of 85%.
Second we ask, Which RNA isoforms are differentially
expressed across the tissues examined? For each RNA
isoform, the intensities of the isoform-speciﬁc junction
probes were examined across tissues using the Kruskal-Wallis
statistical test. After correcting for multiple testing, about
40% of the 6,216 total alternative splicing events examined
were found to have more than one RNA form that was
differentially expressed, indicating widespread tissue differ-
ences in splicing over the tissues.
Third we ask, Which cassette exons are included differ-
entially between brain (or muscle) and nonbrain (or non-
muscle) tissues? To answer this, we used a regression-based
bootstrapping method, which also allows an estimate of the
relative change in skipping and inclusion in the two sample
groups. We analyzed the intron sequences associated with
exon skipping events that are differentially regulated in brain
or muscle relative to other tissues and found unusual patterns
of sequence conservation that provide new information about
tissue regulation of alternative splicing and its evolution.
Results
Broad Detection of Tissue-Regulated Alternative Splicing
in Mouse Using Microarrays
The general idea of using DNA microarrays with combina-
tions of splice junction and exon probes designed to capture
splicinginformationhasbeenpresentedpreviously[31,35]and
appliedinvariousforms byanumber ofgroupstoquestions of
alternative splicing [32–34,37,38,40]. The speciﬁc DNA micro-
array designed for these experiments uses the Affymetrix
format [43,44] similar to the microarray used previously [35],
except that most mismatch probes were not included. Brieﬂy,
for each gene there is a ‘‘common’’ probe set to determine
whether the gene is expressed, as well as ‘‘isoform-speciﬁc’’
splice junction and exon probe sets able to distinguish
alternative mRNA isoforms (Figure 1A). Each splice junction
probe set contains six 25-mer DNA oligonucleotide probes
tiled across the junction (see Materials and Methods).
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Synopsis
Alternative splicing expands the protein-coding potential of genes
and genomes. RNAs copied from a gene can be spliced differently to
produce distinct proteins under regulatory influences that arise
during development or upon environmental change. These authors
present a global analysis of alternative splicing in the mouse, using
microarray measurements of splicing from 22 adult tissues. The
ability to measure thousands of splicing events across the genome
in many tissues has allowed the capture of co-regulated sets of
exons whose inclusion in mRNA occurs preferentially in a given set
of tissues. An examination of the sequences associated with exons
whose expression is regulated in brain or muscle as compared to
other tissues reveals extreme conservation of intron sequences
nearby the regulated exon. These conserved regions contain
sequence motifs likely to contribute to the regulation of alternative
splicing in brain and muscle cells. The availability of global gene
expression data with splicing level resolution should spur the
development of computational methods for detecting and predict-
ing alternative splicing and its regulation. In addition, the authors
make strong predictions for biological experiments leading to the
identification of components and their mechanisms of action in the
regulation of splicing during mammalian development.
Regulated Exons Found by Splicing MicroarraysAs the junction probes should be speciﬁc for the RNA form
derived by the alternative splicing event that creates the
junction, we ﬁrst asked simply whether each particular
junction is detected in different tissues. To do this, we ﬁrst
determined which genes were likely to be expressed above
background, using the ‘‘common’’ probe set designed to
detect gene expression (Figure 1A). For the alternative
junction probe sets in the genes that were expressed, we then
estimated the probability that the intensity measured by each
junction probe was above background, using an empirical
cumulative distribution function (CDF) (see Materials and
Methods). Thus, to detect the expression of a particular
alternatively spliced RNA from a particular gene, we demand
that both the gene probe set and the junction-speciﬁc probe
set be called expressed. Alternative splicing is then inferred if
two alternative isoforms are both signiﬁcantly expressed.
In the set of adult mouse tissues we studied, a large number
and variety of alternative splicing events were detected using
this ﬁrst method (Table S1). Among the class of expressed
genes for which we could detect at least one alternative event,
we could observe a second alternative event in 18% to 30% of
cases, depending on the type of splicing event. Alternatively
skipped (cassette) exons were the largest class, with 376 exons.
For the purposes of this study, we deﬁned a cassette exon to
be any exon that can be included or skipped in its entirety,
regardless of other alternative splicing events that affect it
(e.g., alternative 39 or 59 splice sites). RT-PCR validation
experiments (Table S2) indicate that the true-positive rate
(fraction of situations in which a splice junction predicted to
be expressed by the microarray is detected by RT-PCR) is
about 85% (217 RT-PCRs; a reaction is one primer pair with
cDNA from one tissue, designed to detect two isoforms, or
434 independent splice junction tests [see Materials and
Methods]), and the false-negative rate (fraction of times that a
splice junction that could not be detected on the microarray
is detected by RT-PCR) is about 47%, due to the relatively
greater ability of RT-PCR to detect low levels of gene
expression (data not shown).
Simple present or absent determinations of RNA forms
containing particular splice junctions such as those shown in
Table S1 are likely to miss changes in alternative splicing that
do not involve large changes in overall transcript level. To
improve our detection of smaller-scale changes in alternative
splicing, we asked which alternative RNA forms are differ-
entially expressed across tissues. To determine this, we used
the Kruskal-Wallis test to determine whether the intensity
measured for probes speciﬁc for each junction in different
samples was likely to come from the same or different
distributions. Alternative splicing is again inferred if two
alternative RNA forms (differing at alternative junctions) are
both signiﬁcantly differentially expressed (Table 1).
For most classes of alternative splicing events, nearly 5-fold
more alternative events were identiﬁed by the Kruskal-Wallis
test than by simple presence-absence tests, as expected. By
this analysis, about 40% of the alternative RNA forms we
could detect are differentially expressed across tissues. Using
the PCR tests for those genes in Table S2 for which at least
ﬁve tissues were tested, we ﬁnd that the Kruskal-Wallis test
Figure 1. Array Design and Analysis of Splicing-Sensitive Microarray Data
(A) Probe design and expression counts of alternative event-specific
probe sets. Probe sets were designed to both the skipping splice
junctions and include splice junctions, as well as the alternative exons
when possible, ensuring that probe sets are specific to the exon skipped
or included spliced isoforms. Probe sets for constitutive portions of the
gene were used to measure overall expression of the locus.
(B) Scatterplot of skip probe set intensity versus include probe set
intensity for Biaip exon 15 in brain (squares) and nonbrain (circles) tissue
samples. Each data point is derived from one RNA sample and represents
the skip-to-include ratio for that sample. The lines represent the robust
regression coefficient (constrained to go through the origin) for each
tissue group. The log2 difference in the slopes is 2.53, indicating 5.7-fold
inclusion in brain relative to nonbrain tissues.
DOI: 10.1371/journal.pcbi.0020004.g001
Table 1. Differential Expression of Alternative Splicing Event
Isoforms
Event Type Total Events
on the Array
Alternative Percent
Alternative
Alt Cassette 3,217 1,140 35%
Alt 39 530 240 45%
Alt 59 350 158 45%
Alt mutually exclusive exons 27 11 41%
Alt transcription start 1,537 700 42%
Alt transcription end 555 232 45%
‘‘Total Events on the Array’’ indicates the number of alternative events that had probe sets for more than one
isoform. ‘‘Alternative’’ indicates the number of events for which at least two RNA forms were differentially
expressed. ‘‘Percent Alternative’’ is the percentage of events where more than one RNA form was differentially
expressed.
DOI: 10.1371/journal.pcbi.0020004.t001
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Regulated Exons Found by Splicing Microarraysgives an 89% true-positive rate (25 of 28 isoforms predicted
to be differentially expressed versus being detected or not
detected by nonquantitative RT-PCR across at least ﬁve
tissues) with a 7% false-positive rate (2 of 28).
These validation data are consistent with other studies
using microarrays to detect alternative splicing [32,37].
During validation, evidence for new isoforms not identiﬁed
in the EST/mRNA data was obtained in about 20% of cases
(data not shown), indicating that much alternative splicing
remains undiscovered, as other studies have also noted [32].
Since our microarray design relies on initial evidence for
alternative splicing from EST/mRNA data, we would not
expect our current analysis to detect such events except
during validation by RT-PCR. We conclude that, although
limited in sensitivity, the data and our analysis are speciﬁc
and likely provide a conservative representation of splicing
events across the adult mouse transcriptome.
Detection of Strongly Regulated Alternative Splicing in
Brain and Muscle Tissues
A critical challenge is to distinguish differences in
alternative splicing from changes in transcript level, as the
overall transcription of individual genes varies greatly across
tissues. To focus on brain- and muscle-enriched alternative
splicing independent of changes in transcript level, we
devised a simple method to identify pairs of alternative
splice junctions whose expression relative to each other
differs greatly between two subsets of tissues in our dataset. A
measure of alternative splicing is the ratio of skipped isoform
to included isoform. We wanted to test whether this ratio is
different between two groups of tissues (e.g., brain and
nonbrain). A natural measure of the overall ratio is the slope
of the line created by plotting the skip probe set intensities
versus the include probe set intensities for many samples
from a tissue group. If there is a consistent alternative
splicing pattern within the group, these values should fall on a
line with a slope given by the skip/include ratio (Figure 1B).
We then test for differences between the two groups of tissues
by bootstrapping multiple rounds of robust regressions for
each group and comparing the slopes of the regression lines
for the two groups of tissues (Figure 1B; see Materials and
Methods). The difference in the slope between the tissue
groups is a measure of the difference in the average ratio of
skipping to inclusion for the indicated exon in the two
different groups of tissues over a wide range of transcription
levels. In the example shown, exon 15 of the membrane-
associated guanylate kinase (MAGUK) gene Baiap1 (MAGI-1)
is preferentially included more than 4-fold in brain tissues
compared to the nonbrain tissues in which the gene is
expressed (Figure 1B).
By searching this way through all the cassette exons within
expressed genes (as deﬁned by intensity measured by
‘‘common’’ probe sets), we identiﬁed 171 exons that appear
differentially regulated in brain tissue compared to nonbrain
tissue (Table S3). Of these, 91 are preferentially skipped in
brain, whereas 80 are preferentially included in brain. To
focus our studies on exons whose regulation is most extreme
between the two groups of tissues, we further examined the
set where the log2 difference between regression slopes was
greater than 2. This criterion resulted in a set of 36 brain-
included and 36 brain-skipped cassette exons whose skip/
include ratios were more than 4-fold different on the average
in brain relative to nonbrain tissues. Details concerning the
genes associated with these exons, as well as a set of muscle-
regulated exons derived by comparison of heart and skeletal
muscle samples with nonmuscle tissues, are found in Tables
S3 and S4. Having identiﬁed sets of exons with similar levels
and patterns of splicing regulation, we compared the nature
of their nearby intron sequences to those of a large control
set of constitutive exons.
Evolutionary Conservation of Intron Sequences Adjacent
to Tissue-Regulated Exons
A number of studies have noted extended regions of high
conservation of intron sequences surrounding ISE and ISS
elements found adjacent to regulated exons (e.g., nPTB [45],
FGFR1, FGFR2 [46,47]). In addition, EST/mRNA-based
studies have noted that alternative exons and their nearby
intron regions are generally conserved in different organ-
isms, suggesting the presence of cis-acting regulatory
elements [22–28]. To examine sequence conservation asso-
ciated with our brain- or muscle-regulated alternative exons
and their nearby introns, we used the program phyloHMM.
phyloHMM uses sequence alignments and phylogenetic trees
to calculate the posterior probability that an observed
alignment results from a conserved rather than a neutral
model of evolution [48,49]. Conservation can be compared
to the positions of exons using tracks displayed by the
University of California Santa Cruz Genome Browser [21].
The brain-included exon 15 of Baiap1 (MAGI-1) is shown as
an example (Figure 2A, see also Figure 1B). In addition to
conservation of the exon, it is clear that intron sequences
adjacent to the exon are highly conserved. Most of the
alternative exons identiﬁed as brain- or muscle-regulated
are associated with conserved adjacent intron sequences
(Figure 2B and 2C).
We systematically analyzed this conservation in our set of
brain-regulated exons compared to constitutive exons in two
ways. First, we asked about the probability of conservation at
each nucleotide position (Figure 2B) as distance from the
exon increases upstream (left) or downstream (right). Both
the brain-included (gray circles) and the brain-skipped (gray
squares) exons are signiﬁcantly more likely to be associated
with conserved intron sequences than about 47,000 con-
stitutive mouse exons (black circles, [24]). The conservation
levels for about 1,000 unselected skipped exons from mouse
that are also skipped in the human transcriptome (gray
triangles, [24]) are lower than those of the extremely
regulated brain exons. This result suggests that extraction
of splicing events by tissue-regulated pattern and magnitude
of regulation using arrays also extracts associated sequence
conservation patterns. Intron nucleotides near brain-in-
cluded exons are even more conserved than those that are
preferentially skipped (Figure 2B). The probability of con-
servation generally decreases with distance from the exon
although not smoothly. There appear to be ‘‘bumps’’ centered
about 50 nucleotides downstream of the 59 splice site and
about 70 nucleotides upstream of the 39 splice site, suggesting
that many brain-included and brain-skipped exons are more
likely to have more conserved nucleotides in these regions
(Figure 2B). In general, the 39 splice site region upstream of
the regulated exon is more extensively conserved for a longer
distance than the region downstream of the exon adjacent to
the 59 splice site (Figure 2B).
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Regulated Exons Found by Splicing MicroarraysSecond, we asked about the median probability of
conservation of the entire set of 100 nucleotides immediately
upstream (Figure 2C, left) or downstream (right) for the
brain-included exons and plotted the distribution of their
median conservation probabilities (gray bars) compared to
the constitutive exons (Figure 2C, black bars). The histograms
show that about 30% of the exons in the brain-included set
have upstream intron sequences (39 splice site regions) whose
median probability of conservation exceeds 0.9 (left) com-
pared to less than 1% of constitutive exons. About 20% are
similarly conserved for the downstream (59 splice site) region
(right). In some cases, the conservation of the intronic regions
exceeds that of the exon. Other studies have noted this trend
using alternative exons observed in cDNA libraries [24–26].
Our results using microarrays now allow extraction of tissue
regulation-associated intron conservation for further analysis
(see below).
We were concerned that conservation levels similar to
protein coding sequence might indicate that many exons in
our set had nearby splice sites that could be used to create
larger, protein-coding alternative versions of the exon
through splicing. If true, the high level of conservation could
Figure 2. Conservation of Cassette Exons Preferentially Included in Brain
(A) Extreme conservation in flanking intronic sequences of Baiap1 cassette exon seen in University of California Santa Cruz genome browser.
(B) Median conservation probability at each base 100 base pairs upstream (left) and downstream (right) of the exon for 36 brain-included exons (gray
circles), 36 brain-skipped exons (hollow gray squares), about 1,000 skipped mouse exons conserved and alternatively spliced in both human and mouse
(gray triangles), and about 47,000 constitutive mouse exons (black circles). These last two sets of exons are from an EST/mRNA-based study [24].
(C) Histograms of the median probability of conservation per 100 base pairs upstream and downstream of the brain preferentially included (light gray),
constitutive exons (black), and overlapping regions (dark gray).
DOI: 10.1371/journal.pcbi.0020004.g002
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Regulated Exons Found by Splicing Microarraysbe explained by protein coding rather than a splicing-related
function, despite the absence of evidence for such splicing in
the EST/mRNA data. To test this, we used the program QRNA
[50] to analyze the sequences. QRNA examines pairwise
alignments of orthologous sequences from different organ-
isms (in this case, mouse and human), notes the pattern of
sequence divergence, and evaluates three models of evolu-
tionary constraint: protein coding, RNA structure, and
‘‘other.’’ Using the conserved elements that overlap the
brain-included exon as chosen by phyloHMM [48], usually
including the exons themselves, QRNA predicts that its RNA
structure evolution model ﬁts the data best in 43% of the
regions, whereas the protein coding model ﬁts only 19% of
these regions. In contrast, for 500 conserved regions that
overlap constitutive exons, which usually include only
protein-coding sequence, QRNA predicts the RNA structure
model for only 16% and chooses the protein-coding model
for 69% of the regions. Elimination of the protein-coding
model by QRNA for more than 80% of the regions
overlapping our regulated set is a strong indication that the
conserved sequences associated with regulated exons are
unlikely to represent cryptic protein-coding sequence. We
conclude that the conservation of intronic sequence is likely
due to its function in splicing regulation.
Searching for Regulatory Motifs in the Conserved Regions
near the Tissue-Regulated Alternative Exons
Our sets of exons are deﬁned by similar regulatory patterns
obtained from splicing-sensitive microarray data. In contrast
to alternative exons culled from unselected EST/mRNA
collections in which all regulatory signals are superimposed,
the sequence composition of our brain- or muscle-enriched
exons may allow identiﬁcation of ISE and ISS sequences
particular to the regulatory events that mediate alternative
splicing in these tissues. We wanted to ask whether the
conserved regions contain cis-acting elements known to be
important for splicing regulation. To do this, we examined
the frequency of several known splicing regulator RNA-
binding motifs in the intronic sequences near the 171 brain-
regulated exons to those of a control set of about 47,000
mouse exons that appear constitutively spliced in the mRNA/
EST data [24]. To estimate these frequencies, we used the
consensus motifs that represent the core elements of more
complex recognition sequences. For the regulators PTB and
nPTB, we used CUCUCU [51]. For hnRNP H/F, we used
GGGGG [52]. The consensus sequence used for the Fox-1
family of proteins A2BP1 and RBM9 was GCAUG [53], and for
Nova, it was UCAUY [54]. For hnRNP A1, the consensus motif
of UAGGG was used [55]. The approach of using these simple
representative sequences for frequency determination esti-
mates is conservative, and it may miss related sequence
examples of the motif that nonetheless are functional.
When we compared the frequency of these consensus
sequences near our selected sets of exons to the frequency to
those of the constitutive exons (Figure 3), we found that both
the Nova and the Fox-1 consensus motifs were enriched
signiﬁcantly in the 150 nucleotides of intron sequence
downstream of brain-included exons (P ¼ 3.9 3 10
 7 and 5.3
3 10
 6, respectively), whereas no such enrichment was
observed downstream of the brain-skipped exons (Figure 3).
We observed an enrichment of Fox-1 sites upstream of exons
skipped in muscle, as did Jin et al. [53]; however, too few
observations were made to estimate the statistical signiﬁcance
of this ﬁnding. These data support the idea that these two
splicing factors contribute to the inclusion of nearby exons in
the brain from positions downstream of the regulated exon.
Nova is expressed only in neural tissues and can activate or
repress exon inclusion [10,56–58], in some cases positively
from downstream positions [56,58]. Sequences containing the
Fox-1 motif have also been shown to activate inclusion of
exons from this position [53,59–62], although proteins that
bind it are not restricted to brain [13,14,53,60,61].
In contrast, the PTB/nPTB consensus sequence is signiﬁ-
cantly depleted (P ¼ 4.7 3 10
 3) from the region downstream
of the brain-included exons (Figure 3). Consensus hnRNP F/H
binding sites are signiﬁcantly depleted (P ¼ 2.6 3 10
 3) from
the region upstream of the brain-included exons (Figure 3).
This suggests that the absence of PTB/nPTB binding to the
region downstream of the exon, or absence of hnRNP F/H
binding to the region upstream of the exon, may be
important for proper regulation of some brain-included
exons. hnRNP A1 binding sites did not appear signiﬁcantly
enriched or depleted in either region near the brain-included
exons (P . 0.05). Although we have restricted our search to
the 150 nucleotides proximal to the upstream and down-
stream sides of the regulated exons, we ﬁnd signiﬁcant
enrichment and depletion of intronic sequence motifs known
to inﬂuence alternative splicing. We conclude that selection
of alternative splicing events on the basis of microarray data
results in the identiﬁcation of new candidates for exons
regulated in the brain by RNA binding proteins with Nova
and Fox-1 type speciﬁcities.
Figure 3. Counts of RNA Binding Motifs in Intron Sequences adjacent to
Brain-Regulated Exons
The 100 base pairs upstream and downstream regions for constitutive
exons (control), preferentially brain-included (brain include), and
preferentially brain-skipped exons (brain skip) were evaluated for the
presence of sequences related to binding sites for known splicing
regulators. Sequences used as the consensus binding sites were Nova:
UCAUU or UCAUC; Fox-1: GCAUG; PTB/nPTB: CUCUCU; hnRNP-H/F:
GGGGG; and hnRNP A1: UAGGG.
DOI: 10.1371/journal.pcbi.0020004.g003
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Regulated Exons Found by Splicing MicroarraysIn addition to examining the frequency of the consensus
sequence of known RNA binding factors, we examined the
tissue-regulated exons for novel motifs. To identify new
motifs near tissue-regulated exons, we used the Improbizer
motif-ﬁnding program written by Jim Kent [63]. This
program identiﬁes sequence motifs present in a set of
sequences compared to a background sequence set. As a
background sequence set, we used the upstream or down-
stream regions of a set of about 47,000 exons showing no
alternative splicing in mouse [24]. Improbizer identiﬁed the
Nova motif in the intron sequence downstream from the
brain-included exons, consistent with the increased counts of
the Nova core sequence (Figure 3). Two additional interesting
motifs were found by Improbizer (Figure 4), as well as by
MEME [64,65], although the precise weight matrices of the
motifs differ slightly (data not shown). A motif with consensus
sequence UGYUUUC (Y ¼ C or U) was identiﬁed in the 150
nucleotides upstream of brain-included exons (Figure 4A).
Although pyrimidine rich, this motif is found above a
background of constitutive exons and thus may not be a
typical feature of polypyrimidine tracts generally associated
with the 39 splice site. To estimate the probability of ﬁnding
this motif by chance, the input sequences were randomly
permuted 1,000 times, and the Improbizer program was run
for each randomized set. The UGYUUUC motif found in the
natural sequences had a higher score than any motif found in
the 1,000 randomized control runs. We further examined the
counts of all 4-mers in the 150 nucleotides upstream using a
binomial test to look for differences in the proportion of 4-
mers compared to the control set. Five 4-mers had signiﬁcant
P-values after using the Bonferroni correction to account for
multiple testing with the signiﬁcance level of 0.05/256¼1.953
10
 4. The 4-mers found to be enriched were CUCC, CUCU,
CUUU, UCCU, and UGCU. Two of the ﬁve signiﬁcant 4-mers
Figure 4. New Motifs in the Tissue-Regulated Exons
(A) A new motif UGYUUUC found upstream of brain-included exons. The logo is shown above, and the graph of the frequency of this motif in different
regions of the brain-enriched exons is below.
(B) A sequence similar to the recognition sites for SF1 and QK proteins is enriched near the 59 splice site of the muscle-included exons. The logo is
shown above, and the graph of the frequency of the core of this motif in different regions of the muscle-enriched exons is below.
(C) Locations of multiple copies of conserved sequences matching the motif in (B) found in a conserved ‘‘bump’’ downstream of a muscle-included (and
brain-skipped) exon 16 in the Vldlr gene.
DOI: 10.1371/journal.pcbi.0020004.g004
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izer, further indicating that this motif is not likely to have
occurred by chance. None of the above 4-mers was enriched
in the 150 nucleotides upstream of the exons preferentially
skipped in brain. This motif could either repress exon
inclusion in non-brain tissues or activate inclusion in brain
tissues. No splicing factors are known to bind this sequence at
this time.
A motif with striking similarity to the branchpoint
consensus sequence UACUAAC is found in the intron region
downstream of the 59 splice site of heart and skeletal muscle–
included exons (Figure 4B). While the small number of
sequences makes testing the statistical signiﬁcance of ﬁnding
this motif using Improbizer difﬁcult, the biological impor-
tance of this sequence motif has been thoroughly demon-
strated in several contexts (see Discussion). To investigate this
further, we performed an analysis similar to that of the other
known motifs (Figure 3) and measured the frequency of the
core of the branchpoint motif (Figure 4B, CUAAC) near
muscle exons compared to constitutive exons. We found that
CUAAC is enriched downstream of the 59 splice site in muscle
exons but not upstream of the exons compared to constitutive
exons. Near some muscle-included exons such as Vldlr exon
16, there are multiple copies of this motif contained within
regions that are highly conserved among mammals (Figure
4C). We propose that a protein recognizes this motif and
activates inclusion of nearby exons in heart and skeletal
muscle. After identifying this motif in the muscle-included
exons, we revisited the brain exons and determined the
frequency of the core CUAAC sequence in the nearby regions.
The frequency of CUAAC is enriched downstream of the
brain-included exons as well, whereas exons skipped in brain
showed no signiﬁcant enrichment. This suggests that CUAAC
motifs downstream of the 59 splice site may activate exon
inclusion in both muscle and brain cells.
Paralogous Brain-Included Exons in Three Members of the
MAGUK Family
Four of the 22 members of the MAGUK family present in
the mouse genome have exons that appear to be differentially
included in brain tissues. The guanylate kinases are important
in the transport, anchoring, and signaling of synaptic
receptors and ion channels (for review, see [66]). The kinase
domain no longer functions, and it appears that the MAGUK
family has evolved to act as a scaffold to bind other proteins.
The four MAGUK family members found to have brain-
included exons are called Cask, Dlgh1, Baiap1 (human
ortholog is Magi-1), and 4732496O19Rik (human ortholog is
Magi-3). The latter two are paralogs apparently resulting from
gene duplication, and their regulated alternative exons are
also paralogous (Figure 5). Another paralog called Acvrinp1
(human ortholog is Magi-2) also contains a paralogous exon
that is alternatively spliced in humans. Although there is no
mouse cDNA representing the skipping event, RT-PCR
analysis conﬁrmed that the Acvrinp1 exon is also alternatively
spliced in mouse, being included in the brain but skipped in
nonbrain tissues (Figure 5C). In all three genes, the alternative
exon lies just downstream of a C-terminal PDZ domain and is
not predicted to inﬂuence nonsense-mediated decay, suggest-
ing that the protein encoded by these alternative exons may
inﬂuence PDZ-mediated protein-protein interactions in the
brain (for review, see [67]).
All three of the MAGI gene alternative exons have nearby
intronic sequences that are highly conserved with their
respective orthologous regions in other organisms (Figure
6A). The 89-nucleotide exon 15 of mouse Baiap1 lies in a
highly conserved region (Figure 6A, see also Figure 2A), and
there is EST evidence supporting its alternative splicing in
species as distant as chicken. The tissue patterns of
alternative splicing for these paralogous exons are similar,
as detected by the microarray data and conﬁrmed by RT-PCR
(Figure 5 and data not shown). The intron sequences
downstream from the 59 splice site are highly conserved in
the orthologs (Figure 6A), but comparison of the paralogous
intron sequences shows that they have diverged considerably
in overall sequence (Figure 6B). The same conservation
pattern holds for the exons and the region upstream of the
exons. This appears to conﬂict with the expectation that
alternative exons of common descent and regulatory pattern
should possess common regulatory elements. This expect-
ation holds for orthologs despite occupying different
genomes but apparently not for paralogs sharing similar
regulatory proﬁles within the same genome.
Discussion
Identification of Brain and Muscle-Regulated Exons Using
Microarrays
A signiﬁcant challenge of using DNA microarrays to study
alternative splicing is separating changes in overall gene-
Figure 5. Tissue-Regulated Splicing Controls the C-Terminal Sequences
of Mouse MAGI Proteins
(A) Microarray intensity (top) and RT-PCR results (bottom) for the
alternative exon in Baiap1.
(B) Microarray intensity (top) and RT-PCR results (bottom) for the
alternative exon in 653047C02Rik.
(C) RT-PCR results (bottom) for the alternative exon in Avricp1 (this gene
was not present on the array).
(D) Diagram of the alternative splicing and coding patterns at the 39 end
of the mouse MAGI genes.
DOI: 10.1371/journal.pcbi.0020004.g005
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An additional difﬁculty is that splicing cannot be assessed in
tissues in which the gene is not expressed, a situation that
creates missing data, which in turn can confound many
statistical similarity metrics. Numerous groups are now using
microarrays to study the regulation of splicing, and all have
had to develop methods to account for transcriptional effects
[31–41]. Examining the fold change of isoform-speciﬁc probes,
normalized by the change in probes common to all tran-
scripts, has worked well in treatment and control experimen-
tal designs [31,39,41]. More sophisticated model-based
methods that either directly estimate isoform concentration
[35,38] or ﬁnd loci that do not ﬁt a constitutive exon model,
thus identifying candidate alternative exons [32,68], have been
applied to tissue panels to detect the occurrence of alternative
splicing differences between the tissues. Other methods have
used pairwise anticorrelation to identify cases where a
constitutive exon model is inappropriate [37]. By comparing
splicing in grouped sets of tissue samples (e.g., brain versus
nonbrain), we were able to use a relatively simple regression-
based statistical test to identify regulated alternative splicing
(Figure 1B). This test isolates our parameter of interest, the
relative use of pairs of alternative junctions, and identiﬁes a
signiﬁcant difference in this parameter between two sample
populations. Using this method, we discovered hundreds of
tissue-regulated alternative splicing events (Tables S3 and S4).
The identiﬁcation of a splicing event as tissue-regulated
does not necessarily imply that all cells within a tissue share
the same splicing pattern. Many tissues are heterogeneous
populations of distinct cell types, and dramatic examples of
differences in splicing in individual cells within a tissue are
known (for review, see [69]). Our method appears sufﬁcient to
capture splicing events despite this heterogeneity. However,
it is possible that many instances of cell type–speciﬁc splicing
are missed because the superposition of the splicing patterns
from the tissue generates a mixed signal. Such cell type–
speciﬁc splicing events could be identiﬁed using puriﬁed cell
populations from the same tissue.
Extreme Conservation near Alternative Exons
Large blocks of conserved sequence are found in the introns
both upstream and downstream of the alternative exons
identiﬁed in our microarray data (Figure 2), consistent with
earlier computational studies based on EST/mRNA data [24–
26]. The high levels of conservation do not appear to be due to
cryptic protein-coding function as determined by QRNA,
even though the conserved regions analyzed often included a
portion of the coding exon. It is possible that these highly
conserved regions contain multiple RNA binding protein
motifs that act in concert to regulate the splicing of the
alternative exon. A selective pressure on the type, number,
and order of these RNA binding proteins could explain the
large blocks of conserved sequence seen near these exons (for
examples and additional references, see [45–47]). It is hard to
visualize how such large blocks of conservation are required
given the ﬂexible way that RNA protein binding sites can
function in other contexts. It seems likely that the secondary
RNA structures of these regions play some role in the binding
of proteins that inﬂuence alternative splicing or may play
some direct role themselves by an as-yet-unknown mecha-
nism. It is difﬁcult to make convincing secondary structure
models of these conserved regions since they lack the
phylogenetic variation necessary to support such models.
Much future work remains to be done to determine the
functional elements that regulate these alternative exons.
Figure 6. Multiple Alignment of the Flanking Intron Sequences Downstream of the Alternative Exons from Baiap1 (MAGI-1), Acvrinp1 (MAGI-2), and
4732496O19Rik (MAGI-3) and the Orthologous Sequences from Rat, Human, Dog, and Chicken
While the orthologous sequences have high conservation between them (A), the paralogous sequences have diverged considerably (B). The 59 splice
sites are at the left. Genome sequences similar to TACTAAC are between gray bars. In the region downstream of the 59 splice site these may act as
regulatory binding sites for SF1, quaking (QK), or some other factor. Fox-1 sites are shown between black bars.
DOI: 10.1371/journal.pcbi.0020004.g006
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Enriched for Known Motifs
Nova has previously been shown to regulate alternative
splicing in the brain [10,56–58,70], and the enrichment of
Nova sites in the brain-included exons extends the potential
list of Nova splicing targets. Our data show that the 150
nucleotides downstream of the brain-included exons has a
signiﬁcant increase in Nova-1 consensus motif sites, whereas
we could not detect enrichment in the regions immediately
upstream of brain-included exons. These results suggest that
most often Nova stimulates exon inclusion in the brain from
positions in the150 nucleotides downstream of the exon
(Figure 3).
Similarly, the consensus motif for Fox-1 proteins is
enriched downstream but not upstream of the brain-included
exons, suggesting that like Nova-1, Fox-1 proteins contribute
most often to activation of exons from positions to the 59
splice site side (Figure 3). At least one other mouse protein,
RBM9, has an RRM family RNA recognition motif essentially
identical to that of vertebrate Fox-1 [13,14,53] and is
therefore likely to recognize the UGCAUG sequence. Unlike
Nova proteins, the expression of Fox-1 proteins is not
normally restricted to brain [13,14,53]; thus, the Fox-1 motif
is not strictly brain associated and is known to regulate
nonneural splicing events [13,14,23,53,59–62,71,72]. Previous
EST/mRNA-based studies [23,25,59] have noted an enrich-
ment of the Fox-1 motif near brain-included alternative
exons but not the enrichment of the Nova motif. This
illustrates the utility of empirical data that accurately
enriched our exon set for strong regulation.
Discovery of New Motifs Associated with Regulated Exons
An unexpected ﬁnding is that a sequence motif similar to
the yeast branchpoint consensus sequence UACUAAC is
found enriched downstream of exons included in heart and
skeletal muscle (Figure 4). Although the set of muscle-
included exons was too small for robust statistical evaluation
of the Improbizer results, this motif is known to be
biologically important (see below). In addition, the frequency
of occurrence of the core of the motif CUAAC is signiﬁcantly
enriched in this region (Figure 4B). Several proteins have
been shown to bind sequences related to this motif. The best
understood in molecular terms is SF1, a KH-domain family
member that binds the pre-mRNA branchpoint during intron
recognition [17,73,74] and is not known to bind and regulate
exon inclusion from downstream sites. An NMR structure of
the SF1 KH-domain bound to UACUAAC RNA provides a
detailed picture of the contacts that lead to sequence
speciﬁcity [17]. Recent work has revisited the question of
whether SF1 is required for splicing of every mammalian
intron [75,76], opening the possibility that it might have
functions beyond those as a general splicing factor. SF1 is
broadly expressed, so if it has a special role in regulating
muscle exon inclusion it will be interesting to know how it
might carry out both a general and a regulatory function in
the same cells. Strikingly, muscle-speciﬁc exons appear to be
depleted of CUAAC sequences upstream of the intron,
suggesting they may have weak SF1-branchpoint interactions.
Other metazoan proteins with similar KH domains that
bind nearly identical sequences include Caenorhabditis elegans
GLD-1 and the vertebrate QK known to regulate cytoplasmic
mRNA stability through sites in the 39 UTR of their target
mRNAs [15,16,77]. QK is expressed in brain, heart, and
muscle [20], and one QK isoform (QK-I5) enters the nucleus,
where it may regulate splicing [19,78]. Experiments to test the
role of QK in splicing regulation clearly show it can inﬂuence
splicing [18]; however, these studies predated the identiﬁca-
tion of the QK binding site [15]. Thus, it is unclear whether
QK splicing regulation [18] is directly mediated through the
UACUAAC-like QK binding site. In addition, the mouse
genome contains at least two additional genes (KHDRBS2 and
KHDRBS3) predicted to contain KH domains with binding
speciﬁcities that could be similar to SF1 and QK, although
little is known of their expression or localization. Further
work will be necessary to determine if and how this sequence
inﬂuences exon inclusion in heart and skeletal muscle.
Although many studies of heart- and muscle-speciﬁc splicing
have identiﬁed motifs and factors using directed analysis of
one or a few substrates, none has identiﬁed this motif.
We have also identiﬁed a novel UGYUUUC motif that is
enriched upstream of the exons most strongly included in
brain (Figure 4A). Thus far, no RNA binding protein is
reported to recognize UGYUUUC. It is interesting to note
that whereas exons preferentially included in brain are near
intron sequences enriched for known ISE motifs, those
preferentially skipped in the brain are not. It is likely that
many exons that are preferentially skipped in brain may be
preferentially included in other tissues, and their tissue-
speciﬁc activation signatures are superimposed and thus lost
by the heterogeneous grouping of ‘‘not brain.’’ It is important
to note that our analysis does not guarantee that every
important motif has been identiﬁed. We have selected the
new motifs we discuss as contrasting examples: one novel with
no known biological explanation, and the other with well-
demonstrated biological functions in other contexts.
Conservation in Orthologs and Divergence in Paralogs:
Why Maintain Similar Splicing Patterns Using Distinct
Sequences?
Nature has provided an interesting case study with the
paralogous alternative exons of the MAGUK proteins (Figures
5 and 6). The paralogous alternative exons in the MAGUK
genes suggest either that there are many combinations of
distinct RNA binding sites that can mediate a similar tissue-
speciﬁc splicing pattern or that other levels of regulation
besides primary RNA sequence exist. The striking difference
in the primary sequence of the exons, and nearby intronic
sequence, coupled with the apparent similarity in splicing
proﬁles conﬂicts with the parsimonious hypothesis that
alternative exons resulting from a gene duplication event
should have similar RNA binding motif proﬁles regulating
them. It is possible that the regulation of the exon occurs
through some more distal site as other studies have shown for
both Nova [56] and Fox-1 [53,60] or could even reside within
the exons themselves. Yet the high level of conservation in
orthologous species suggests that the primary sequence of
these exons, and nearby introns, is important for the function
of these genes. It is also possible that there are subtle
differences in the regulation of the paralogous exons that we
cannot distinguish looking at the heterogeneous cell pop-
ulations (e.g., neurons and glia) that make up a tissue extract.
Even if there are differences within regulation between
subpopulations of cells in brain, it seems plausible to expect
that at least the mechanism of skipping in other tissues might
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extremely conserved intronic sequence, much larger than
typical RNA binding motifs (Figure 2), the QRNA prediction
that these blocks are not protein coding, and the paralogous
alternative exons with common regulation from divergent
sequence (Figures 5 and 6) all suggest that there are other
levels of evolutionary constraint on these regions in addition
to RNA binding motifs that inﬂuence alternative splicing. In
addition to the possible direct effect of the primary sequence
motifs we have noted, the folded structure of these RNA
regions could be important, even though we cannot now
determine the nature of these folds. Alternatively, relatively
small contributions of the primary sequence to splicing
efﬁciency could make very large contributions to evolu-
tionary ﬁtness and reproduction of vertebrates that could be
difﬁcult to assay in the laboratory. It will be important to
understand the functional basis for this unusual conservation.
A recent study has suggested that evolutionary forces act to
produce either multiply duplicated gene families poor in
alternative splicing or single genes with complex alternative
splicing [8]; however, the MAGUK gene family appears to
have taken an intermediate path.
Materials and Methods
Design of microarray to monitor alternative splicing in the mouse.
Oligonucleotide microarrays to study mouse alternative splicing were
designed as part of this collaboration and constructed by Affymetrix
(Santa Clara, California, United States). All cDNA and EST
information used for developing the mouse splicing sensitive chips
were aligned to the February 2002 genome freeze of the mouse
genome. Brieﬂy, mouse cDNA sequences were aligned to the genome
using psLayout, an early version of BLAT [79]. Orientation of cDNA
was determined using EST read directions, coding sequence
annotations, and poly(A) signals. Alignment discontinuities between
cDNA and genome bordered in the genome by GT–AG, AT–AC, or
GC–AG were interpreted as introns. The program AltMerge [80] was
run on the aligned cDNAs to create a gene model that describes the
different paths through the gene created by alternative splicing, for
each gene.
DNA oligonucleotide probes are synthesized on a glass surface by
photolithographic methods [43,44]. Probes used in this work were 25
nucleotides long and restricted to 7113711 adjacent positions. Each
microarray has 5.05 3 10
6 probes. Probes are grouped conceptually
into ‘‘probe sets’’ of six to ten probes designed to measure the same
transcriptfeature.Threetypesofprobesetswerecreatedforeachgene
model. One set, the ‘‘gene probe set,’’ consists of eight to ten probes
placed in the regions of the gene found in all mRNA isoforms and is
meant to measure the overall transcript level from the gene. There are
gene probe sets for 15,000 RefSeq genes in addition to those for
alternative splicing events in genes not identiﬁed in RefSeq. A second
kindofprobesetisthe‘‘splicejunctionprobeset,’’ whichconsistsofsix
probes that step across a splice junction, centered at positions 3, 2,
 1,þ1,þ2,andþ3relativetothejunction.Thethirdkindofprobesetis
the ‘‘exon probe set,’’ which consists of variable number of probes for
distinct alternative exon regions in the gene model. After design and
manufacture using the February 2002 assembly of the mouse genome,
the probes were reanalyzed and remapped to the May 2004 assembly.
The microarray has probes sufﬁcient for the detection of more than
6,000 alternative splicing events. All probes are ‘‘perfect match’’
probes and there are no ‘‘mismatch’’ probes. Thus, we used alternative
data analysis strategies to subtract background nonspeciﬁc hybrid-
ization signals from the true hybridization signals (described below). A
small set of known alternatively spliced genes was annotated by hand,
andprobesetsdesignedforthesegenesincludedmismatchandperfect
match probes.
Animal care and maintenance. Male and female 8-wk-old C57/BLJ6
were obtained when necessary from Simonsen Labs (Gilroy,
California, United States). Animals were provided with unlimited
access to food and water and were housed on site for at least 2 wk
before use.
Tissue dissection. Tissues were dissected from individual age- and
weight-matched mice. Animals were deeply anesthetized with an
overdose of Nembutal by intraperitoneal injection prior to any
dissection. Brain tissues used were cerebellum, cortex, olfactory bulb,
pineal gland, hindbrain, median eminence, thalamus, and cerebellar
hemispheres. Nonbrain tissues used were spinal cord, heart, lung,
liver, spleen, kidney, testis, ovary, mammary gland, salivary gland,
esophagus, stomach, small intestine, colon, and skeletal muscle. Males
were used for all tissues, except that estrus cycle–matched females
were used for mammary gland and ovary. Tissues from different
individuals were not pooled, with the exception of olfactory bulb,
pineal gland, testis, and ovary. Tissues were frozen in liquid nitrogen,
and RNA was extracted immediately or stored after freezing at 80 8C
until RNA extraction.
RNA extraction. RNA from cortex, cerebellum, olfactory bulb,
thalamus, hindbrain, pineal gland, median eminence, cerebellar
hemispheres, lung, liver, spleen, testis, colon, kidney, small intestine,
ovaries, mammary gland, and salivary gland was extracted using the
Invitrogen Micro-to-Midi Total RNA Puriﬁcation System (catalog
12183–018; Carlsbad, California, United States). RNA from skeletal
muscle, heart, and esophagus was extracted using the Qiagen RNEasy
kit for Fibrous Tissue (catalog 74704; Valencia, California, United
States). All RNA samples were treated with DNase I for 30 min at 37
8C, extracted twice with phenol/chloroform and once with chloro-
form, and ethanol precipitated. RNA samples were run on an Agilent
Bioanalyzer (Agilent Technologies, Palo Alto, California, United
States) to determine RNA integrity as measured by the ratio of 28S to
18S rRNA. RNA concentration was measured using either a regular
spectrophotometer or a Nanodrop short–path length spectropho-
tometer.
Labeling protocol. Tissue RNA from at least three individual
animals (or three separate groups of animals in the case where tissues
needed to be pooled to obtain sufﬁcient RNA) was used to make
target for hybridization to triplicate oligonucleotide microarrays.
RNA was primed with random hexamers and reverse transcribed.
After the reaction was completed, RNA was removed from the
reaction by alkaline hydrolysis and the cDNA was puriﬁed using
Qiagen PCR Quick Puriﬁcation Kit. A typical reaction started with 5
to 6 lg of total RNA usually yielded about 3 lg of cDNA. The cDNA
was then fragmented using DNase I in an empirically controlled
reaction that yields DNA fragments of 50 to 200 bases. This
fragmented cDNA was then end labeled using terminal deoxynucleo-
tidyl transferase and DNA-Labeling-Reagent-1a (DLR-1a), which is a
biotinylated dideoxynucleoside triphosphate. Labeled targets were
mixed with Affymetrix Eukaryotic mix (biotin-labeled oligos for
which control probes exist on the chip as internal controls), and
heated at 99 8C for 5 min before hybridizing to microarray. Targets
were hybridized to chips in 7% DMSO solution for 16 h overnight at
50 8C. Microarrays were washed and processed with anti-biotin
antibodies and streptavidin-phycoerythrin according to the standard
Affymetrix protocol. After scanning the chips and aligning the grids
to the scanned image, intensity values were extracted using the
software associated with the Affymetrix scanner.
Normalization and analysis of intensity data. Normalization and
analysis of intensity values from the DNA microarrays were done
using a quantile normalization [81], and probe set summaries were
derived using the Robust Multi-chip Analysis (RMA) procedure
[82,83] with two modiﬁcations. The ﬁrst modiﬁcation was to remove
all probes with 17 or more continuous bases that match to any other
mouse transcript, in order to minimize cross-hybridization issues.
The second modiﬁcation was to use the mode of the probe intensity
values of similar GC content probes for the background estimate of a
particular probe. For example, if a probe has a GC count of 16, then
the mode of the intensity of all the probes with a GC count of 16 was
used as a background estimate.
Global detection and comparison of alternative splicing. The DNA
microarrays used in this study lack mismatch probes, preventing use
of the standard Affymetrix MAS 5.0 protocols for calling the absence
or presence of a target complementary to a particular probe set in
the sample [42]. We ﬁrst removed from consideration all probes with
17 or more continuous bases that spuriously match to any other
mouse transcript, in order to minimize cross-hybridization issues.
Next the remaining probe intensities for an array were used to
construct an empirical CDF. The empirically derived CDF was used to
calculate an empirical P-value that a particular probe’s intensity
arose from the background of all probes. This corresponds to using
the relative rank of a probe’s intensity as a P-value for the probability
that the probe’s intensity is due to background. Probes were stratiﬁed
by G þ C count as probes with a higher G þ C count are known to
generally have more nonspeciﬁc binding due to the thermodynami-
cally more favorable G þ C base pairing. For each probe set, the
median P-value of the set of individual probes in the probe set was
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expression for biological replicates were combined using Fisher’s v
2
method [84] to derive a probability of expression in a particular
sample. To detect the expression of a particular alternatively spliced
RNA from a particular gene, we ﬁrst determine that the gene is
expressed. For each expressed gene, we then determine whether RNA
containing either of two or more alternative splice junctions is
detectable using the isoform-speciﬁc probes according to the method
described above. If probe sets for two or more alternative isoforms
are called ‘‘present’’ in any sample of the data, this is taken as
evidence for alternative splicing. As the probe selection process is
constrained at splice junctions and we are using only perfect match
probes, rather than both perfect match and mismatch probes, these
estimates may not be as robust as those derived from the MAS 5.0
algorithm.
Estimating overall differential expression of alternatively spliced
RNAs across tissues. For each alternative splicing event, the junction
probe sets that would hybridize to individual isoforms were identiﬁed
and the probes they contained were used for the Kruskal-Wallis test
[85]. Individual probe intensity values were normalized as described
above, and probe intensities from the replicates from each tissue
were grouped together. The Kruskal-Wallis test as implemented by
the R function kruskal.test was used to test the hypothesis that the
probe intensities come from identical populations. If the resulting P-
value was small enough, the null hypothesis was rejected and the
alternative hypothesis that the probes were differentially expressed
across tissues was accepted. To determine an appropriate value for
the 0.01 signiﬁcance level, we ﬁrst ran 12,740 Kruskal-Wallis tests on
randomly selected probe sets and found the a value associated with
the 1% quantile of randomly selected probes to be 1.975486 3 10
 3.
To account for multiple testing, a Bonferroni-corrected a value of
1.9754863 10
 3/1.2740310
4 ¼1.550617310
 7 was used as a P-value
cutoff for signiﬁcance. If more than one alternative RNA form was
differentially expressed, this was taken as evidence of alternative
splicing across the tissues. These data are presented in Table 1.
Capturing strong differential tissue regulation of exon inclusion
and skipping. Regression coefﬁcients between the include and the
skip probe set intensities for brain and nonbrain (or heart and
skeletal muscle versus nonmuscle) tissues were compared to
determine if the level of inclusion or skipping of each exon is
different between the two populations of tissues. To avoid assuming
normality, a bootstrap method was used to determine the signiﬁcance
of the difference between the regression coefﬁcient for two tissue
populations using the method described by Wilcox [85]. Brieﬂy, the
number of times that the regression coefﬁcient for one population is
greater than the other is tabulated for all of the bootstrap samples
and is used to calculate the signiﬁcance of the difference between the
two populations. Formally, we wish to test the null hypothesis that the
skip/include ratios are the same in the brain and nonbrain groups,
H0 : bbrain ¼ bnonbrain. We resample the data with replacement D
times. For each resampling d, Id¼1i fbbrain bnonbrain . 0 and Id¼0i f
bbrain   bnonbrain ¼ 0. Thus, P(H0) ¼ 2 * min[(Rd I/D), 1   (RdI/D)]. We
rejectthenullhypothesisH0ifP(H0),10
 4.Toimplementthistest,we
took 10,000 bootstrap samples from the two populations (D¼10,000),
and a robust regression coefﬁcient was calculated for each one using
iterated re-weighted least squares as implemented by the rlm function
inR[86].Thus,ifonegroupoftissuesT1usestheincludeisoformmore
than another group of tissues T2, then a subsample of T1 should also
use the include isoform more than a subsample of T2. Looking at
10,000 sets of such subsamples strengthens the argument that the
differences in skip/include ratios in the two groups are not due to
chance. All regression calculations were required to go through the
origin (zero intensity), since without transcription there can be no
included or skipped transcripts. To help ensure that the genes
analyzed had independent evidence for expression before analyzing
their splice junction signals, only samples in which the gene probe set
was called present (see previous section) with a P-value of  0.75 were
used in the regression calculation. Furthermore, a minimum of eight
hybridizations in which the gene was considered expressed for each
tissue group was required before a splicing event could be considered
for analysis. The difference between regression slopes can be used to
estimate the magnitude of the fold difference in splicing between the
two groups of tissues. Only events for which all bootstrap regression
tests consistently called one slope greater than another (P , 0.0001)
were used in subsequent analysis.
Motif ﬁnding and calculation of motif enrichment. To identify new
motifs we used Improbizer [63]. As described in the supplement to
[63], Improbizer searches for motifs in DNA or RNA sequences that
occur with improbable frequency using an algorithm adapted from
MEME. The algorithm works with position-weight matrices (PWMs).
At each position in a motif, the PWM contains a probability for each
of the four nucleotides. The algorithm (1) constructs an initial PWM
based on the ﬁrst 6-mer in the input sequence set, (2) ﬁnds the best
placement of the PWM on each sequence in the input, (3) constructs a
new PWM by taking a weighted average of the PWMs found in step 2
and assesses whether adding or subtracting a column from either end
of the PWM will increase the score, (4) repeats steps 2 through 4 until
there is no change in the PWM, (5) then constructs a new initial PWM
based on the next 6-mer in the input, and (6) repeats steps 2 through
6 over a user-speciﬁed subset of the input (by default all of the ﬁrst 20
input sequences), (7) reports the best scoring PWM, (8) probabilisti-
cally erases the occurrences of the best scoring PWM from each
sequence, and (9) iterates steps 1 through 8 until it has found as many
PWMs as the user has requested. A key to the algorithm is the scoring
of PWM placements. The score is an odds score: Pobserved/PWM/Pobserved/
background model where the numerator is the product of the
probabilities of the nucleotides at a particular position according
to the PWM, and the denominator is the probability according to a
simple Markov chain constructed by examining frequencies of
nucleotide occurrences throughout a large background (nonenriched
for the motifs of interest) sequence set. Further details and the source
code are available from W. J. Kent (kent@soe.ucsc.edu). There is also
a Web site (http://www.soe.ucsc.edu/;kent/improbizer/improbizer.
html) with an online version of the algorithm.
As a background sequence set, we used about 47,000 exons that
show no alternative splicing in mouse [24]. For motif frequency
determination, the counts of consensus motifs were calculated for the
150 nucleotides upstream and downstream from the exon of interest.
Counts were compared to those of the about 47,000 constitutive
exons using Pearson’s v
2 test statistic, as implemented by the R
function prop.test, to determine the likelihood (P-value) that the
motif counts of interest could have come from the same distribution
found in the constitutive exons.
RT-PCR validation of microarray predictions. cDNA was generated
from about 2 lg of total RNA using the TaqMan Reverse Tran-
scription Reagents kit (Applied Biosciences, Foster City, California,
United States) using a mixture of oligo-dT and random hexamers,
following the manufacturer’s instructions. For PCR, about 50 to 100
ng of cDNA was used as a template with primer pairs designed to
amplify the region containing the skipped exon. Reactions used Taq
Polymerase (Promega, Madison, Wisconsin, United States) and were
run for 25 to 35 cycles at annealing temperatures appropriate for the
primer pairs used. PCR products were run out on 2% agarose gels
and stained with ethidium bromide.
Supporting Information
Table S1. Presence Absence Determination of Alternative RNA
Forms
Found at DOI: 10.1371/journal.pcbi.0020004.st001 (22 KB PDF).
Table S2. RT-PCR Testing of Array Predictions
Found at DOI: 10.1371/journal.pcbi.0020004.st002 (22 KB PDF).
Table S3. Brain-Regulated Exons
Found at DOI: 10.1371/journal.pcbi.0020004.st003 (23 KB PDF).
Table S4. Muscle-Regulated Exons
Found at DOI: 10.1371/journal.pcbi.0020004.st004 (15 KB PDF).
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